業績
2023/07/20

Hamaguchi S, Watanabe A, Nakamoto Y, Aita T, Naganuma T, Takahashi S, et al. Antiviral medications for mild-to-moderate COVID-19 in Japan: a gap of timing between clinical trials and real-world scenarios in a fast-changing pandemic. Annals of Clinical Epidemiology [Internet]. 2023;5(3):65–73.